Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, today announced the initiation of a strategic partnership with Kaiser Permanente's Southern California Permanente Medical Group in order to enhance the diagnosis and treatment of ovarian cancer.
from The Medical News http://ift.tt/1CV1kEg
from The Medical News http://ift.tt/1CV1kEg
No comments:
Post a Comment